over 2,000 subjects. Webster (1962) reported more side-effects from ferrous sulphate taken twice a day than from a similar dose of slow-release ferrous sulphate also taken twice a day. Almost half the subjects he was studying, however, suffered from gastrointestinal irritation or ulcerative colitis, and it is difficult to judge how many of the symptoms were due to underlying disease rather than the iron therapy.
In studies in which radioactive iron has been used to investigate the absorption from slow-release preparations (Bothwell, Pirzio-Biroli, and Finch, 1958 ;  Crossland-Taylor, Keeling, and Cromie, 1965) the latter have been shown to be less well absorbed than similar doses of ordinary ferrous sulphate. There is little justification, therefore, for expecting slow-release iron to be more effective in therapy.
The idea of being able to treat patients with a single daily dose is attractive, but it would appear from the present data that no specific benefit is to be derived by using a slow-release preparation.
Ferrous fumarate is less soluble than ferrous sulphate, and in a recent study with 59Fe-labelled pills (Callender and Warner, 1969) to compare the absorption of iron from different therapeutic preparations in individual subjects, and this paper reports our results.
Materials and Methods
The use of the counter in studies of absorption has been reported elsewhere (Callender, Witts, Warner, and Oliver, 1966) .
Forty-four subjects, divided into five groups, were selected for the investigation. The purpose of the study was fully explained to each subject and all agreed to take part. Three subjects were members of the hospital staff and were initially considered to be normal, but one was found to have a serum iron of only 32 pug./100 ml. The remaining 41 were patients with untreated or partially treated iron deficiency. None had received iron therapy for at least two weeks before the test. In all except six the haemoglobin was 10 g. or more. Groups 1, 2, 3, and 5 (see below) were roughly similar with regard to the degree of anaemia and iron deficiency; the mean haemoglobin values were 118, 11-7, 119, and 11-7 g./100 ml. respectively, and the mean serum iron 46, 36, 46, and 50 iug./100 ml. respectively. Subjects in group 4 were on the whole less anaemic and less iron-deficient; mean haemoglobin 13 8 g./100 ml. and mean serum iron 88 ptg./ 100 ml. (Fig. 1) .
Because of the great variability of absorption in different subjects two, or in some instances three, preparations were compared in the same individual by sequential tests, the order of tests being randomized. The total radioactivity retained by any one subject was never more than 0 5 /Ci. In these first three groups, single doses only were given of each of the substances under test. The subjects fasted for at least two hours before and two hours after each dose.
In the following two groups a multiple dose technique was used as described by Callender and Warner (1968 In group 3 iron from the ferrous fumarate plus ascorbic acid tablet was better absorbed than from ferrous fumarate alone but no better than iron in the ferrous sulphate tablet (using standard crossover test).
Succinic acid did not enhance absorption of iron from the ferrous sulphate tablet in group 4 (t=1 1349, P>0 2).
When ascorbic acid was added to the ferrous sulphate plus succinic acid eight out of nine subjects in group 5 showed an enhanced absorption of iron, but when the ninth subject, who showed a pronounced difference in the reverse direction, is included there is no statistical difference in the paired observations (t=1-2868, P>0-2).
Discussion
The results of the present investigations agree with those of in finding an enhancing effect of succinic acid on absorption of iron when given in a liquid preparation, but not in tablet form. Hallberg and Silvell (1966) , however, investigated further the effect of succinic acid as a promoter of iron absorption from iron tablets, using a double isotope multiple-dose technique to compare the relative utilization of iron from different preparations given on alternate days for 10 days. Their subjects were blood donors who had donated blood about six times a year for a varying period of time and were all considered to be iron-deficient. From observations on a total of 80 subjects they found that both succinic acid and monosodium succinate had a significant enhancing effect on absorption of iron from ferrous sulphate.
In our studies the lack of significant effect of the succinic acid in group 4 may be because this group contained fewer iron-deficient subjects and the dose was given with a meal. This, however, does not apply to group 2. In group 5, where the combined effect of succinic acid and ascorbic acid was tested, eight out of nine subjects showed an enhanced absorption of ferrous sulphate. A very great difference in the reverse direction in one subject makes the results not statistically significant. If there is a real effect it clearly needs a larger group of subjects to reveal it.
The range and mean absorption of iron in terms of milligrams per dose (Fig. 4) source from groups 4 and 5, but there does not appear to be any significant difference in the preparation of the tablets. It would seem, therefore, that the greater absorption in group 3 can be accounted for only by variation in absorption between individuals within the groups. The majority of observations on the effectiveness of different iron preparations have been made on different individuals, and for such studies to be valid it is obvious that large groups require to be studied. The use of radioactive labelled material has the advantage that it enables comparisons to be made in individual subjects.
We are indebted to the pharmaceutical firms Astra Hewlett and Glaxo Laboratories for supplies of "Fe-labelled tablets. 
